Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.80B | 57.71B | 61.68B | 60.55B | 56.98B | 53.08B |
Gross Profit | 8.43B | 8.17B | 8.75B | 8.50B | 8.16B | 7.10B |
EBITDA | 1.41B | 2.35B | 2.07B | 1.13B | 2.71B | 142.24M |
Net Income | 1.39B | 1.72B | 1.34B | 432.74M | 2.06B | -382.69M |
Balance Sheet | ||||||
Total Assets | 39.38B | 37.86B | 42.27B | 37.41B | 36.35B | 34.22B |
Cash, Cash Equivalents and Short-Term Investments | 5.94B | 4.22B | 4.32B | 3.10B | 2.52B | 3.19B |
Total Debt | 8.32B | 7.73B | 8.68B | 9.34B | 7.71B | 8.11B |
Total Liabilities | 20.93B | 18.87B | 24.48B | 22.13B | 21.38B | 21.05B |
Stockholders Equity | 18.46B | 19.00B | 17.79B | 15.28B | 14.96B | 13.17B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 434.42M | 1.93B | -1.41B | -1.70B | 1.43B |
Operating Cash Flow | 0.00 | 466.26M | 2.00B | -1.07B | -1.32B | 1.64B |
Investing Cash Flow | 0.00 | 740.15M | -13.53M | 246.97M | 1.21B | -77.30M |
Financing Cash Flow | 0.00 | -1.30B | -890.73M | 1.39B | -656.62M | -1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥9.19B | 21.08 | 4.29% | -25.41% | -45.60% | ||
72 Outperform | ¥8.71B | 8.03 | 2.50% | -51.97% | -56.67% | ||
67 Neutral | ¥12.02B | 6.90 | 2.79% | -6.44% | 28.42% | ||
63 Neutral | $33.79B | 5.85 | -11.85% | 1.81% | 5.29% | -18.24% | |
61 Neutral | ¥9.36B | 141.98 | 1.72% | -8.06% | ― | ||
55 Neutral | ¥2.59B | 160.51 | ― | 50.79% | -59.24% | ||
43 Neutral | ¥3.84B | 31.45 | 1.73% | -8.12% | -102.86% |